Impaired learning and memory in Pitx3 deficient aphakia mice: A genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

Neurobiology of Disease

Volumn 31, Issue 3, 2008, Pages 406-412

  Ardayfio, Paul ^a,b   Moon, JiSook ^a   Leung, Ka Ka Amanda ^a   Youn Hwang, Dong ^c   Kim, Kwang Soo ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CHA University   (South Korea)

Author keywords

Cognition; Dopamine; Parkinson's disease; Pitx3; Striatum

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APHAKIA; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FOOD PREFERENCE; GENETIC MODEL; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ROTAROD TEST; SOCIAL BEHAVIOR; STATE DEPENDENT LEARNING; TASK PERFORMANCE;

ANIMALS; APHAKIA; AVOIDANCE LEARNING; COGNITION DISORDERS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; FEEDING BEHAVIOR; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; PARKINSON DISEASE; SOCIAL BEHAVIOR; TRANSCRIPTION FACTORS;

EID: 49549100675     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.05.017     Document Type: Article

References (44)

1. Agid Y., Ruberg M., et al. Parkinson's disease and dementia. Clin. Neuropharmacol. 9 Suppl 2 (1986) S22-S36
2. Allain H., Lieury A., et al. Procedural memory and Parkinson's disease. Dementia 6 3 (1995) 174-178
3. Bosboom J.L., Stoffers D., et al. Cognitive dysfunction and dementia in Parkinson's disease. J. Neural. Transm. 111 10-11 (2004) 1303-1315
4. Bove J., Prou D., et al. Toxin-induced models of Parkinson's disease. NeuroRx 2 3 (2005) 484-494
5. Bronnick K., Aarsland D., et al. Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. Acta Psychiatr. Scand. 112 3 (2005) 201-207
6. Caston J., Hilber P., et al. Effect of training on motor abilities of heterozygous staggerer mutant (Rora(+)/Rora(sg)) mice during aging. Behav. Brain Res. 141 1 (2003) 35-42
7. Cools R. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 30 1 (2006) 1-23
8. Di Chiara G., and Morelli M. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis. Adv. Neurol. 60 (1993) 102-106
9. Ding Y., Restrepo J., et al. Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease. Neurobiol. Dis. 27 1 (2007) 11-23
10. Duff K., Mold J.W., et al. Medical burden and cognition in older patients in primary care: selective deficits in attention. Arch. Clin. Neuropsychol. 22 5 (2007) 569-575
11. Dujardin K., and Laurent B. Dysfunction of the human memory systems: role of the dopaminergic transmission. Curr. Opin. Neurol. 16 Suppl 2 (2003) S11-16
12. Dyer R.S., Hammond M.A., et al. Influence of enucleation upon two-way avoidance behavior of rats, hamsters, chinchillas and BALB/cJ mice. Physiol. Behav. 14 2 (1975) 211-216
13. Farr S.A., Banks W.A., et al. Blind mice are not impaired in T-maze footshock avoidance acquisition and retention. Physiol. Behav. 76 4-5 (2002) 531-538
14. Guttman M. Receptors in the basal ganglia. Can. J. Neurol. Sci. 14 3 Suppl (1987) 395-401
15. Hwang D.Y., Ardayfio P., et al. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res. Mol. Brain Res. 114 2 (2003) 123-131
16. Hwang D.Y., Fleming S.M., et al. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J. Neurosci. 25 8 (2005) 2132-2137
17. Kas M.J., van der Linden A.J., et al. Phenotypic segregation of aphakia and Pitx3-null mutants reveals that Pitx3 deficiency increases consolidation of specific movement components. Behav. Brain Res. 186 2 (2008) 208-214
18. Lauterbach E.C. The neuropsychiatry of Parkinson's disease. Minerva. Med. 96 3 (2005) 155-173
19. Lemke M.R., Fuchs G., et al. Depression and Parkinson's disease. J. Neurol. 251 Suppl 6 (2004) VI/24-VI/27
20. Lione L.A., Carter R.J., et al. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19 23 (1999) 10428-10437
21. Nunes I., Tovmasian L.T., et al. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 100 7 (2003) 4245-4250
22. Papapetropoulos S., Argyriou A.A., et al. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J. Neurol. 252 10 (2005) 1223-1228
23. Pascual-Leone A., Grafman J., et al. Procedural learning in Parkinson's disease and cerebellar degeneration. Ann. Neurol. 34 4 (1993) 594-602
24. Pittler S.J., and Baehr W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc. Natl. Acad. Sci. U. S. A. 88 19 (1991) 8322-8326
25. Rojas P., Joodmardi E., et al. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol. Psychiatry 12 8 (2007) 756-766
26. Roncacci S., Troisi E., et al. Implicit memory in parkinsonian patients: evidence for deficient skill learning. Eur. Neurol. 36 3 (1996) 154-159
27. Sarazin M., Deweer B., et al. Procedural learning and striatofrontal dysfunction in Parkinson's disease. Mov. Disord. 17 2 (2002) 265-273
28. Schrag A., Hovris A., et al. Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat. Disord. 12 1 (2006) 35-41
29. Schrag A., Morley D., et al. Impact of Parkinson's disease on patients' adolescent and adult children. Parkinsonism Relat. Disord. 10 7 (2004) 391-397
30. Singh B., Wilson J.H., et al. Motor deficits and altered striatal gene expression in aphakia (ak) mice. Brain Res. 1185 (2007) 283-292
31. Smidt M.P., and Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8 1 (2007) 21-32
32. Smidt M.P., Smits S.M., et al. Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra. Cell Tissue Res. 318 1 (2004) 35-43
33. Smidt M.P., Smits S.M., et al. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131 5 (2004) 1145-1155
34. Sprengelmeyer R., Canavan A.G., et al. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases. Mov. Disord. 10 1 (1995) 51-65
35. Thomas V., Reymann J.M., et al. Assessment of procedural memory in Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 20 4 (1996) 641-650
36. Uekermann J., Daum I., et al. Depressed mood and executive dysfunction in early Parkinson's disease. Acta Neurol. Scand. 107 5 (2003) 341-348
37. Vakil E., and Herishanu-Naaman S. Declarative and procedural learning in Parkinson's disease patients having tremor or bradykinesia as the predominant symptom. Cortex 34 4 (1998) 611-620
38. van den Munckhof P., Luk K.C., et al. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130 11 (2003) 2535-2542
39. van den Munckhof P., Gilbert F., et al. Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease. J. Neurochem. 96 1 (2006) 160-170
40. Van Raamsdonk J.M., Pearson J., et al. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 25 16 (2005) 4169-4180
41. Vriezen E.R., and Moscovitch M. Memory for temporal order and conditional associative-learning in patients with Parkinson's disease. Neuropsychologia 28 12 (1990) 1283-1293
42. Wallen A., and Perlmann T. Transcriptional control of dopamine neuron development. Ann. N.Y. Acad. Sci. 991 (2003) 48-60
43. Weintraub D., Moberg P.J., et al. Dimensions of executive function in Parkinson's disease. Dement. Geriatr. Cogn. Disord. 20 2-3 (2005) 140-144
44. Zgaljardic D.J., Foldi N.S., et al. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J. Neural. Transm. 111 10-11 (2004) 1287-1301